Nefopam 60 mg tds vs placebo
Total adverse events · patients with pain management in rheumatoid arthritis
Nefopam 60 mg tds may leads to higher total adverse events compared with placebo (low certainty).
1 finding from 1 review
- RR 4.11 [1.58, 10.69]2 studies · 104 participantsLow